Optimer binders against three therapeutic targets to support drug validation and potential clinical trial applications ...

Touchlight has expanded its mbDNA platform with the introduction of three new circular DNA architectures: sscDNA, hsscDNA, and dscDNA.

Agreement includes approximately $350 million in cash and upfront technology license fees for Evotec’s continuous manufacturing platform.

Kuvalanka brings over 20 years of experience in biopharmaceutical leadership, including finance, business development, and corporate strategy.

The research collaboration agreement will offer new chemical entity (NCE)-eligible pro-drug candidates to people affected by blinding eye conditions.

Ailux has announced a strategic collaboration with Eli Lilly and Company to accelerate the discovery and development of bispecific antibodies.

Join USP experts Dr. Ravi Kiran Kaja and Dr. G. Prabhakar Reddy on Dec. 9 at 11:00 AM ET for updates on System Suitability Standards and General Chapters & —driving more reliable E&L testing and ...

Kaigene Inc. has entered into an exclusive global licensing agreement with Celltrion Inc. for two of Kaigene's nonclinical-stage assets, KG006 and KG002.

Merck has reached an agreement with Dr. Falk Pharma to discontinue an existing contract concerning co-development and co-commercialization rights in certain territories for MK-8690.

Simtra BioPharma Solutions is advancing a dual-continent expansion aimed at boosting capacity for sterile injectable drugs.

Boehringer Ingelheim and CDR-Life have announced a new global licensing agreement to develop CDR-Life’s CDR111 for autoimmune diseases.

Magnet Biomedicine, a biopharmaceutical company, has appointed Bharat Reddy, Ph.D., as its new Chief Business Officer.